'Sorafenib dose' presentation slideshows

Alan P Venook, MD University of California, San Francisco, USA

First interim results of GIDEON: oncologists and non-oncologists appear to use sorafenib differently. Alan P Venook, MD University of California, San Francisco, USA. R Lencioni, JA Marrero, M Kudo, K Nakajima, F Cihon, SL Ye. ASCO conflict of interest disclosure for Alan P Venook.

376 views • 26 slides